Publications by authors named "Peter C Bates"

Claim this Profile
V
Vildagliptin: a novel DPP-4 inhibitor with pancreatic islet enhancement activity for treatment of patients with type 2 diabetes.
Smiljana Ristic, Peter C Bates

Drugs Today (Barc)· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency.
Kazuo Chihara, Ekaterina Koledova, Akira Shimatsu, Yuzuru Kato, Hitoshi Kohno, Peter C Bates

Eur J Endocrinol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult GH deficiency in Japanese patients: effects of GH treatment in a randomised, placebo-controlled trial.
Kazuo Chihara, Ekaterina Koledova, Akira Shimatsu, Yuzuru Kato, Hitoshi Kohno, Peter C Bates

Eur J Endocrinol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.
Jochen Seufert, Georg Lübben, Karin Dietrich, Peter C Bates

Clin Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
Smiljana Ristic, Peter C Bates

Diabetes Technol Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability of a reusable insulin pen, HumaPen Ergo, by patients with type 1 and type 2 diabetes.
Smiljana Ristic, Peter C Bates, Jane M Martin, Julie A Llewelyn

Curr Med Res Opin· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients.
Andrea F Attanasio, Simon Howell, Peter C Bates, Paul Frewer, John Chipman

J Clin Endocrinol Metab· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.
Anne Kehely, Peter C Bates, Paul Frewer, Martin Birkett, Werner F Blum

J Clin Endocrinol Metab· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.
Andrea F Attanasio, Peter C Bates, Ken K Y Ho, Susan M Webb, Richard J Ross

J Clin Endocrinol Metab· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirmation of severe GH deficiency after final height in patients diagnosed as GH deficient during childhood.
Andrea F Attanasio, Simon Howell, Peter C Bates, Werner F Blum, Paul Frewer

Clin Endocrinol (Oxf)· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis